This investigational drug aims to reduce the number of eosinophils in the esophagus, thus reducing inflammation, pain and swallowing difficulties.
A study to evaluate a new treatment for acyclovir-resistant HSV infections in immunocompromised subjects.
A trial to evaluate the efficacy and safety of study drug for preventative treatement of HAE Type 1 and Type II.
303-771-9000
